Lapatinib Ditosylate from Mexico
Lapatinib ditosylate is a dual tyrosine kinase inhibitor for HER2-positive breast cancer. The core quinazoline structure (aromatic heterocyclic with nitrogen) places it under HTS 2933.99.75.00 as a drug.
Duty Rate — Mexico → United States
6.5%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Declare as 'Lapatinib ditosylate monohydrate' if hydrated form per CoA
• Include bioequivalence data if generic import competing with originator